zepbound mounjaro tirzepatide (Tirzepatide) Eli Lilly weight-loss drug appears

On Thursday, the Food and Drug Administration said Eli Lilly's tirzepatide, sold as Zepbound for weight loss and Mounjaro to treat diabetes, is no longer in short supply

Total cumulative loss by week 16 often reaches 15 to 25 pounds

Published: 2025-05-05 Updated: 2025-05-06 4 mins Zepbound is an FDA-approved prescription medication that contains tirzepatide, a once-weekly injectable used to support chronic weight management in adults with obesity or certain weight-related health conditions

Get prescribed online and delivered to your door.

Why not losing weight on semaglutide discussions often overlook the opposite problem: losing weight too rapidly

2026 savings card reduces monthly cap to $100 for covered patients [13] CALL YOUR INSURANCE Verify Your Specific Coverage Verify Your Specific Coverage Even though it takes a little more time, we recommend calling so you can speak with a person who may have more information than the online directory or PDF formulary listing